Thanks for that Nick8. I know the info related to the US FDA - which in some senses is more important than Aussie approvals. Reading it, a therapeutic and preventative vaccine for herpes would seem to fit the criteria for most of the FDA criteria for fast-tracking, especially when one takes into account the increasing evidence of the possible herpes causation in alzheimers.
The New Admedus, page-16
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.09 |
Change
-0.110(0.90%) |
Mkt cap ! $255.5M | |||
| Open | High | Low | Value | Volume |
| $12.19 | $12.19 | $11.60 | $118.1K | 9.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 621 | $11.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.09 | 116 | 1 |
View Market Depth
| Last trade - 14.20pm 01/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |